Skip to main content
Press release July 28, 2026

Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

Nautilus Biotechnology, Inc. (NAUT)

SEATTLE, July 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Business Highlights Recognized first revenue in
View original release